-
-
-
-
-
-
-
Vertex to acquire Crinetics Pharmaceuticals for $10 billion
-
-
-
-
-
-
-
Vertex to Announce First Quarter 2026 Financial Results on May 4th
-
-
-
-
-
-
-
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
-
-
-
-
-
-
-
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
-
-
-
-
-
-
-
Vertex (VRTX) PT Lowered to $420 at RBC Capital
-
-
-
-
-
-
-
Goldman lists stocks offering stability and visibility amid global uncertainty
-
-
-
-
-
-
-
Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10
-
1,229,200 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


